Antithrombin concentrate use in children: A multicenter cohort study

Journal of Pediatrics

Volumn 163, Issue 5, 2013, Pages

  Wong, Trisha E ^a,b   Huang, Yuan Shung ^c   Weiser, Jason ^d   Brogan, Thomas V ^b   Shah, Samir S ^d,e   Witmer, Char M ^f  

^a PUGET SOUND BLOOD CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN;

ADOLESCENT; ANTITHROMBIN DEFICIENCY; ARTICLE; CHILD; CHRONIC DISEASE; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CONGENITAL LUNG DISEASE; EXTRACORPOREAL OXYGENATION; FEMALE; GROUPS BY AGE; HUMAN; HYPERCOAGULABILITY; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OFF LABEL DRUG USE; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TERTIARY HEALTH CARE;

EID: 84886722281     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.06.036     Document Type: Article

References (39)

1. G.M. Rodgers Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update Thromb Haemost 101 2009 806 812
2. L.E. Franzen, S. Svensson, and O. Larm Structural studies on the carbohydrate portion of human antithrombin III J Biol Chem 255 1980 5090 5093
3. T. Edmunds, S.M. Van Patten, J. Pollock, E. Hanson, R. Bernasconi, and E. Higgins Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin Blood 91 1998 4561 4571
4. S.T. Olson, I. Bjork, R. Sheffer, P.A. Craig, J.D. Shore, and J. Choay Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement J Biol Chem 267 1992 12528 12538
5. R.C. Tait, I.D. Walker, D.J. Perry, S.I. Islam, M.E. Daly, and F. McCall Prevalence of antithrombin deficiency in the healthy population Br J Haematol 87 1994 106 112
6. P.S. Wells, M.A. Blajchman, P. Henderson, M.J. Wells, C. Demers, and R. Bourque Prevalence of antithrombin deficiency in healthy blood donors: a cross-sectional study An J Hematol 45 1994 321 324
7. S.H. Orkin, D.G. Nathan, D. Ginsburg, A.T. Look, D.E. Fisher, and S.E. Lux Hematology of infancy and childhood Vol 2 2003 W.B. Saunders Company Philadelphia (PA)
8. ATryn for injections: U.S. Package Insert. GTC Biotherapeutics, Inc. Framingham, MA. November 2010.
9. U.S. Food and Drug Administration. Cumulative List of Orphan Products Designations and Approvals. 1999. http://www.fda.gov/ohrms/dockets/dailys/00/ mar00/030100/lst0094.pdf. Accessed May 22, 2013.
10. U.S. Food and Drug Administration. Approval Letter - ATryn. February 6, 2009. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm134046.htm. Accessed May 22, 2013.
11. C. Kozul, F. Newall, P. Monagle, E. Mertyn, and V. Ignjatovic A clinical audit of antithrombin concentrate use in a tertiary paediatric centre J Pediatr Child Health 48 2012 681 684
12. J. Mongelluzzo, Z. Mohamad, T.R. Ten Have, and S.S. Shah Corticosteroids and mortality in children with bacterial meningitis JAMA 299 2008 2048 2055
13. C. Feudtner, R.M. Hays, G. Haynes, J.R. Geyer, J.M. Neff, and T.D. Koepsell Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services Pediatrics 107 2001 E99
14. B. Schmidt, P. Gillie, L. Mitchell, M. Andrew, C. Caco, and R. Roberts A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome Am J Respir Crit Care Med 158 1998 470 476
15. D. Bassler, D. Millar, and B. Schmidt Antithrombin for respiratory distress syndrome in preterm infants Cochrane Database Syst Rev 4 2006 CD005383
16. W.D. Kreuz, W. Schneider, and U. Nowak-Gottl Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency - a feasibility pilot study Eur J Pediat 158 Suppl 3 1999 S187 S191
17. R. von Kries, H. Stannigel, and U. Gobel Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation Eur J Pediatr 144 1985 191 194
18. L. Mitchell, M. Andrew, K. Hanna, T. Abshire, J. Halton, and J. Wu Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study Thromb Haemost 90 2003 235 244
19. U. Nowak-Gottl, N. Kuhn, J.E. Wolff, J. Boos, B. Kehrel, and B. Rath Inhibition of hypercoagulation by antithrombin substitution in E. coli L-asparaginase-treated children Eur J Haematol 56 1996 35 38
20. S. Storti, L. Pagano, R. Marra, A. Grilli, G. Falappa, and A.M. De Gaetano Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome Blood Coagul Fibrinolysis 1 1990 743 745
21. A.A. Ribeiro, D.M. Lourenco, C.F. Toledo, M.A. Noguti, and D.R. Borges Antithrombin III concentrate use in patients with cirrhosis with coagulation disorders Rev Assoc Med Bras 43 1997 189 194
22. A. Kowal-Vern, V. McGill, J.M. Walenga, and R.L. Gamelli Antithrombin(H) concentrate infusions are safe and effective in patients with thermal injuries J Burn Care Rehabil 21 2000 115 127
23. N. Shin-Nakai, H. Ishida, T. Yoshihara, T. Imamura, K. Yokoi, and Y. Kasubuchi Control of hepatic veno-occlusive disease with an antithrombin-III concentrate-based therapy Pediatr Int 48 2006 85 87
24. S.D. St Peter, D.C. Little, C.M. Calkins, G.W. Holcomb III, C.L. Snyder, and D.J. Ostlie The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis J Pediatr Surg 42 2007 704 708
25. R.P. Dellinger, M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, and R. Jaeschke Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 2008 296 327
26. A. Afshari, J. Wetterslev, J. Brok, and A.M. Moller Antithrombin III for critically ill patients Cochrane Database Syst Rev 3 2008 CD005370
27. M. Kanbak, B. Oc, M.A. Salman, T. Ocal, and M. Oc Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery Blood Coagul Fibrinolysis 22 2011 593 599
28. J.H. Lemmer Jr., and G.J. Despotis Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery J Thorac Cardiovasc Surg 123 2002 213 217
29. M.S. Avidan, J.H. Levy, H. van Aken, R.O. Feneck, R.D. Latimer, and E. Ott Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass J Thorac Cardiovasc Surg 130 2005 107 113
30. A. Koster, T. Fischer, M. Gruendel, A. Mappes, W.M. Kuebler, and M. Bauer Management of heparin resistance during cardiopulmonary bypass: the effects of five different anticoagulation strategies on hemostatic activation J Cardiothorac Vasc Anesth 17 2003 171 175
31. M.R. Williams, A.B. D'Ambra, J.R. Beck, T.B. Spanier, D.L. Morales, and D.N. Helman A randomized trial of antithrombin concentrate for treatment of heparin resistance Ann Thorac Surg 70 2000 873 877
32. N.M. Haines, P.T. Rycus, J.B. Zwischenberger, R.H. Bartlett, and A. Undar Extracorporeal Life Support Registry Report 2008: neonatal and pediatric cardiac cases ASAIO J 55 2009 111 116
33. L.L. Sell, M.L. Cullen, G.C. Whittlesey, S.T. Yedlin, A.I. Philippart, and M.P. Bedard Hemorrhagic complications during extracorporeal membrane oxygenation: prevention and treatment J Pediatr Surg 21 1986 1087 1091
34. B. Stiller, J. Lemmer, F. Merkle, V. Alexi-Meskishvili, Y. Weng, and M. Hübler Consumption of blood products during mechanical circulatory support in children: comparison between ECMO and a pulsatile ventricular assist device Intensive Care Med 30 2004 1814 1820
35. Extracorporeal Life Support Organization. International Summary, ECMO Registry. Ann Arbor, Michigan. Jan 2013. http://www.elsonet.org/index.php/ registry.html. Accessed July 3, 2013.
36. R.A. Niebler, M. Christensen, R. Berens, H. Wellner, T. Mikhailov, and J.S. Tweddell Antithrombin replacement during extracorporeal membrane oxygenation Artif Organs 35 2011 1024 1028
37. M.E. Pollock, J.T. Owings, and R.C. Gosselin ATIII replacement during infant extracorporeal support Thromb Haemost 1995 936
38. B. Urlesberger, G. Zobel, S. Rödl, D. Dacar, I. Friehs, and B. Leschnik Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation J Artif Organs 20 1997 708 712
39. S. Agati, G. Ciccarello, D. Salvo, G. Turla, A. Undar, and C. Mignosa Use of a novel anticoagulation strategy during ECMO in a pediatric population: single-center experience ASAIO J 52 2006 513 516